Is this the week?, page-54

Us based investor and partner funding arrangements usually show a little more
variety and represent much deeper pockets compared to so called sophisticated investors in OZ which play the same mud games over and over in achieving discount placements.
We are controlled the other way round, our price is not reflecting company making news to be around the corner, we are supressed in price, today by just another garden variety of bot hitting the trading.

We were repeatedly told that we negotiate with the leaders in the US biotech market.
I believe many in OZ think just too small to appreciate the outlook of this company.
Only when we established our San Diego offices I therefore felt that the time to invest heavily in this company had arrived.
I maintain that view.

Ocular programs are facilitating the broader applications of our tech, CNS and other programs will take the company to the next level.

all IMO